BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:RMC-5127 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of RMC-5127\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07349537-2709@assetmemo.bio
DTSTAMP:20261121T005726Z
DTSTART;VALUE=DATE:20280430
DTEND;VALUE=DATE:20280501
SUMMARY:RMC-5127: Phase 1 readout est. (NCT07349537)
DESCRIPTION:RMC-5127\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: Study 
 of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors\nEstim
 ated primary completion: April 2028. This is a ClinicalTrials.gov estimate
 \, not a confirmed readout date\, and it can move.\nDrug page: https://ass
 etmemo.bio/drug/rmc-5127#upcoming-events\nRegistry record: https://clinica
 ltrials.gov/study/NCT07349537
URL:https://assetmemo.bio/drug/rmc-5127#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
